![Tauhid Ali](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tauhid Ali
Vorstandsvorsitzender bei Oak Hill Bio Corp.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Josh Distler | M | 48 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
Christian Angermayer | M | 45 |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 5 Jahre |
James Peyer | M | 37 |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 5 Jahre |
Mark McHale | M | 59 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 Jahre |
Juliette Han | M | - |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 4 Jahre |
Brenton Saunders | M | 56 |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
Steve Jurvetson | M | 57 |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
Edwin Moses | M | 69 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 Jahre |
Ramon Chavez Márquez | M | 60 |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | 4 Jahre |
Ramy Farid | M | 59 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 Jahre |
Paul Farr | M | - |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
David Colpman | M | 62 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 Jahre |
Daniel Curran | M | 57 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 Jahre |
Marie Yurkovich | M | - |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | - |
Maryanna Saenko | F | - |
Cambrian BioPharma, Inc.
![]() Cambrian BioPharma, Inc. BiotechnologyHealth Technology Cambrian Biopharma, Inc. operates as clinical-stage biopharmaceutical company. The company is headquartered in Brooklyn, NY. | - |
Victoria Niklas | M | 64 |
Oak Hill Bio Corp.
![]() Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 8 | 50,00% |
Vereinigtes Königreich | 8 | 50,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tauhid Ali
- Persönliches Netzwerk